Pharmafile Logo

Patients and data tracking

- PMLiVE

UK announces COVID boosters for a “bumpy winter” ahead

A single shot of Pfizer’s COVID-19 vaccine will be offered to 30 million people in the UK including those 50 or over and frontline health and social care workers

- PMLiVE

Orphan status in Europe for lymphoma drug Zynlonta

The ADC Therapeutics antibody-drug conjugate is licensed to treat patients with a common form of non-Hodgkin lymphoma.

Health literacy in the time of COVID-19

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...

Impetus Digital

Rare thoughts & outcomes – navigating pathways to better outcomes in rare

Mobilizing pathway change – what the past 25 years have shown meWelcome to OPEN Health’s second Rare Thoughts & Outcomes theme for 2021 – Navigating pathways to better outcomes. This...

OPEN Health

How to pick the perfect training program for your healthcare professionals

You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...

OPEN Health

Maximize your training investments with learning and development specialists

Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can...

OPEN Health

A day in the life of a PR Account Director

We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health

OPEN Health

Lucid Group’s winning talent team

The Lucid Group talent team has grown with two new Talent Acquisition Partners: Jon Turner and Ellen Field. To help you understand a bit more about them, their role, and the opportunities...

Lucid Group Communications Limited

- PMLiVE

Why you should feel optimistic about the future of healthcare

It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.

Say Communications

- PMLiVE

Valneva shares fall as UK cancels COVID-19 vaccine order

The UK government has cancelled a supply agreement for French vaccine maker Valneva’s COVID candidate VLA2001 over an alleged breach of obligations.

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links